Delivery Order SPE2DB20D1100-SPE2DB24FC7H2

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,211.25 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a completion date of January 12, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,624.70 firm fixed price delivery order is for the supply of NAFTIN 1% GEL 40GM, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract valued at $2,329.53 by the Defense Logistics Agency (DLA) to provide NAFTIN 2% GEL 45GM pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a maximum potential value of $999,999,999.00 and a period of performance...
This federal contract award, valued at $1,080.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 1% GEL 60GM, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
This federal contract award, with an ID of SPE2DB24D2205|SPE2DB25FDZRE, is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567585411 ! NAFTIN 2% GEL 45GM, a pharmaceutical product, with a ceiling value of $4,336.07 and a completion date of March 17, 2025. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,059.36, is for the delivery of Naftin 1% Gel, a pharmaceutical product used to treat fungal skin infections. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,703.00 firm fixed-price delivery order contract is for the supply of NAFTIFINE HCL 1% CREAM 90GM. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of NAFTIN 2% GEL 45GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations registered in the System for Award Management (SAM.gov). The contract, valued at $4,801.13, is a delivery order with a firm fixed price. It has an ultimate completion date of September 12, 2023. The contract is not...
This federal contract award, valued at $1,598.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of NAFTIN 1% GEL 60GM, a pharmaceutical product, with a completion date of September 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025....
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7H2
    Delivery Order

This federal contract award, valued at $1,125.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIN 2% GEL 45GM, a pharmaceutical product, and is a Firm Fixed Price Delivery Order. The contract has no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/17/25, 9:42 AM